Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Détail de l'auteur
Auteur F. BALKWILL |
Documents disponibles écrits par cet auteur (1)
Faire une suggestion Affiner la recherche
Use of interferon in the management of patients with subacute sclerosing panencephalitis / A. BYE in Developmental Medicine & Child Neurology, 27-2 (April 1985)
[article]
Titre : Use of interferon in the management of patients with subacute sclerosing panencephalitis Type de document : Texte imprimé et/ou numérique Auteurs : A. BYE, Auteur ; J. WILSON, Auteur ; F. BALKWILL, Auteur ; D. BRIDGEN, Auteur Année de publication : 1985 Article en page(s) : p.170-175 Langues : Anglais (eng) Index. décimale : PER Périodiques Résumé : Six patients (five male, one female) with subacute sclerosing panencephalitis were treated with purified lymphoblastoid interferon, using a combination of intravenous and lumbar intrathecal routes. The first symptoms of the disorder occurred between seven and 16 years of age, and the length of the illness before treatment varied from 1 1/2 to 12 months. All six patients were in the first clinical stage of the disorder. After a limited period of follow-up there has been no clinical improvement. Nil or low levels of interferon were found in CSF two hours after intravenous injection, but CSF levels of interferon were maintained for at least 24 hours after intrathecal injections. Side-effects of interferon included pyrexial reactions, especially after high-dose intravenous therapy (six), lethargy (four), a transient rise in blood pressure (two) and a reduction in platelet count (six). Staphylococcus epidermidis was grown from the CSF of one patient. Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=587
in Developmental Medicine & Child Neurology > 27-2 (April 1985) . - p.170-175[article] Use of interferon in the management of patients with subacute sclerosing panencephalitis [Texte imprimé et/ou numérique] / A. BYE, Auteur ; J. WILSON, Auteur ; F. BALKWILL, Auteur ; D. BRIDGEN, Auteur . - 1985 . - p.170-175.
Langues : Anglais (eng)
in Developmental Medicine & Child Neurology > 27-2 (April 1985) . - p.170-175
Index. décimale : PER Périodiques Résumé : Six patients (five male, one female) with subacute sclerosing panencephalitis were treated with purified lymphoblastoid interferon, using a combination of intravenous and lumbar intrathecal routes. The first symptoms of the disorder occurred between seven and 16 years of age, and the length of the illness before treatment varied from 1 1/2 to 12 months. All six patients were in the first clinical stage of the disorder. After a limited period of follow-up there has been no clinical improvement. Nil or low levels of interferon were found in CSF two hours after intravenous injection, but CSF levels of interferon were maintained for at least 24 hours after intrathecal injections. Side-effects of interferon included pyrexial reactions, especially after high-dose intravenous therapy (six), lethargy (four), a transient rise in blood pressure (two) and a reduction in platelet count (six). Staphylococcus epidermidis was grown from the CSF of one patient. Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=587